Previous studies have demonstrated that decreased CLEC3B expression indicates poor prognosis in liver cancer patients, possibly because it regulates immune cell infiltration in liver cancer tissue (Xie et al. 2020). The gene discussed is CLEC3B; the disease is liver cancer.